Upneeq (oxymetazoline hydrochloride ophthalmic solution) is a medication used for the treatment of acquired blepharoptosis, which is a condition characterized by drooping or low-lying upper eyelids. Acquired blepharoptosis can be associated with age-related changes in the eyelid muscles or nerve function.
Here's how Upneeq works and some key points about its use:
Mechanism of Action: Upneeq is an alpha-adrenergic agonist. It works by stimulating the dilator muscle of the iris, causing the eyelid to lift.
Application: Upneeq is applied as eye drops directly into the affected eye(s). It is typically used once daily in the morning.
Effectiveness: Upneeq is designed to provide temporary improvement in the appearance of low-lying eyelids. It does not address the underlying causes of blepharoptosis but can help elevate the eyelid for several hours after application.
Duration of Action: The effects of Upneeq are usually noticeable within 5 to 10 minutes after application, with peak effects occurring around 2 hours post-application.
Side Effects: Common side effects may include eye redness, eye irritation, headache, and increased blood pressure. It's important to use Upneeq under the supervision of a healthcare professional who can monitor for potential side effects.
Contraindications: Upneeq may not be suitable for everyone. It is important to inform your healthcare provider about any existing medical conditions, allergies, or medications you are taking before using Upneeq.
Consultation with a Healthcare Provider: Before starting Upneeq or any medication, it's crucial to consult with an eye care professional or healthcare provider. They can assess your specific situation, provide guidance on proper usage, and determine if Upneeq is an appropriate treatment for your condition.
It's important to note that Upneeq is a prescription medication, and its use should be based on a healthcare provider's recommendation after a thorough evaluation of your eye health and overall medical history.
Must be used within 60 days of purchase.